Autonomic neuropathy in Type 2 diabetic patients is associated with hyperinsulinaemia and hypertriglyceridaemia

Diabetic Medicine

Volumn 16, Issue 1, 1999, Pages 49-54

  Gottsater A ^a   Ahmed, M ^a   Fernlund, P ^a   Sundkvist, G ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Autonomic neuropathy; Complications; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; LIPID;

ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE MONITORING; BODY MASS; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT; RISK FACTOR;

AUTONOMIC NERVOUS SYSTEM DISEASES; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; HUMANS; HYPERINSULINISM; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MIDDLE AGED; PARASYMPATHETIC NERVOUS SYSTEM; PROSPECTIVE STUDIES; RISK FACTORS; SYNDROME;

EID: 0032975159     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.1999.00001.x     Document Type: Article

References (44)

1. 1 Garcia M, McNamara P, Gordon T, Kannel W. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 1974; 23: 105-111.
2. 2 Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 123-131.
3. 3 Reaven G. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
4. 4 Jarrett RJ. In defence of insulin: a critique of syndrome X. Lancet 1992; 340: 469-471.
5. 5 O'Brien IAD, O'Hare JP, Levin IG, Corrall RJM. The prevalence of autonomic neuropathy in insulin-dependent diabetes mellitus: a controlled study based on heart rate variability. Q J Med 1986; 61: 957-967.
6. 6 Ewing DJ, Campbell IW, Clarke BF. The natural history of diabetic autonomic neuropathy. Q J Med 1980; 49: 95-108.
7. 7 Sampson MJ, Wilson S, Karagiannis P, Edmonds M, Watkins PJ. Progression of diabetic autonomic neuropathy over a decade in insulin-dependent diabetics. Q J Med 1990; 75: 635-646.
8. 8 Bergström B, Lilja B, Österlin S, Sundkvist G. Autonomic neuropathy in non-insulin dependent (Type 2) diabetes mellitus. Possible influence of obesity. J Intern Med 1990; 227: 57-63.
9. 9 Nilsson H, Bergström B, Lilja B, Juul-Möller S, Carlsson J, Sundkvist G. Prospective study of autonomic nerve dysfunction in Type 1 and Type 2 diabetic patients: 24 hour heart rate variation and plasma motilin levels disturbed in parasympathetic neuropathy. Diabetic Med 1995; 12: 1015-1021.
10. 10 Eriksson KF, Nilsson H, Lindgärde F, Österlin S, Dahlin L-B, Lilja B et al. Diabetes mellitus but not impaired glucose tolerance is associated with dysfunction in peripheral nerves. Diabetic Med 1994; 11: 279-285.
11. 11 Rossi M, Marti G, Ricordi L, Fornasari G, Finardi G, Frationo P et al. Cardiac autonomic dysfunction in obese subjects. Clin Sci 1989; 76: 567-572.
12. 12 Wheeler T, Watkins PJ. Cardiac denervation in diabetes. Br Med J 1973; 4: 584-586.
13. 13 Sundkvist G, Almér L-O, Lilja B. Respiratory influence of heart rate in diabetes mellitus. Br Med J 1979; 1: 924-925.
14. 14 Ewing DJ, Martyn CN, Yound RJ, Clarke BF. The value of cardiovascular autonomic tests: 10 years experience in diabetes. Diabetes Care 1985; 8: 491-498.
15. 15 Landin-Olsson M, Nilsson K-O, Lernmark Å, Sundkvist G. Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus. Diabetologia 1990; 33: 561-568.
16. 16 Gottsäter A, Landin-Olsson M, Fernlund P, Lernmark Å, Sundkvist G. β-cell function in relation to islet cell antibodies (ICA) during the first three years after the clinical diagnosis of diabetes in non-insulin-dependent (type II) diabetic patients. Diabetes Care 1993; 16: 902-910.
17. 17 Gottsäter A, Landin-Olsson M, Lernmark Å, Fernlund P, Sundkvist G. Islet cell antibodies are associated with β-cell failure also in obese adult onset diabetic patients. Acta Diabetol 1994; 31: 226-231.
18. 18 Gottsäter A, Ahmed M, Lilja B, Fernlund P, Sundkvist G. Islet cell antibodies, but not leanness, relate to a better cardiovascular risk factor profile five years after diagnosis of non-insulin dependent diabetes mellitus. Diabetes Care 1996; 19: 60-63.
19. 19 Larsson B, Svärdsudd K, Welin L, Wilhelmsen L, Björntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J 1984; 288: 1401-1404.
20. 20 Jeppsson J-O, Jerntorp P, Sundkvist G, Englund H, Nylund V. Measurement of hemoglobin A1c by a new liquid-chromatographic assay: Methodology, clinical utility, and relation to glucose tolerance evaluated. Clin Chem 1986; 32: 1867-1872.
21. 21 Heding LS. Radioimmunological determination of C-peptide in serum. Diabetologia 1975; 11: 541-548.
22. 22 Burstein M, Scholnik HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970; 11: 583-595.
23. 23 Feldt-Rasmussen B, Mathiesen E, Hegedüs L, Deckert T. Kidney function during 12 months of strict metabolic control in insulin-dependent diabetic patients with incipient nephropathy. N Engl J Med 1986; 314: 665-670.
24. 24 Bröchner-Mortenson J. A simple method for determination of glomerular filtration rate. Scand J Clin Lab Invest 1972; 30: 271-274.
25. 25 Bergström B, Lilja B, Österlin S, Sundkvist G. Autonomic neuropathy in type I diabetes; influence of duration and other diabetic complications. Acta Med Scand 1987; 222: 147-154.
26. 26 Maser RE, Pfeifer MA, Dorman JS, Kuller LH, Becker DJ, Orchard TJ. Diabetic autonomic neuropathy and cardiovascular risk. Pittsburgh Epidemiology of Diabetes Complications Study III. Arch Intern Med 1990; 150: 1218-1222.
27. 27 Ziegler D. Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment. Diabetes/Metab Rev 1994; 10: 339-383.
28. 28 Airaksinen KEJ, Koistinen MJ, Ikäheimo MJ, Pirttiaho H, Huikuri HV, Takkunen JT. Effect of coronary artery disease on parasympathetic cardiovascular reflexes in NIDDM. Diabetes Care 1990; 13: 83-86.
29. 29 Freeman R, Weiss ST, Roberts M, Zbikowski SM, Sparrow D. The relationship between heart rate variability and measures of body habitus. Clin Autonom Res 1995; 5: 261-266.
30. 30 Peterson HR, Rotschild M, Weinberg CR, Fell RD, Mcleish KR, Pfeiffer MR. Body fat and the activity of the autonomic nervous system. N Engl J Med 1988; 318: 1077-1083.
31. 31 Vanninen E, Uusitupa M, Länsimies E, Siitonen O, Laitinen J. Effect of metabolic control on autonomic function in obese patients with newly diagnosed Type 2 diabetes. Diabetic Med 1993; 10: 66-73.
32. 32 Nacht CA, Cristin L, Temler E, Chiolero R, Jequier E, Acheson KJ. Thermic effect of food: possible implication of parasympathetic nervous system. Am J Physiol 1987; 268: E481-E488.
33. 33 Balkan B, Dunning BE. Muscarinic stimulation maintains in vivo insulin secretion in response to glucose after prolonged hyperglycaemia. Am J Physiol 1995; 268: R475-R479.
34. 34 Boyle PJ, Liggett SB, Shah SD, Cryer PE. Direct muscarinic cholinergic inhibition of hepatic glucose production. J Clin Invest 1988; 82: 445-449.
35. 35 Fisher BM, Hepburn DA, Frier BM et al. Pancreatic and pituitary hormonal responses to insulin-induced hypoglycaemia during muscarinic cholinergic blockade in man. Eur J Clin Invest 1992; 22: 614-618.
36. 36 Fabris SE, Thorburn A, Litchfield A, Proietto J. Effect of parasympathetic denervation of liver and pancreas on glucose kinetics in man. Metabolism 1996; 45: 987-991.
37. 37 Ryder REJ, Owens DR, Hayes TM, Ghatei MA, Bloom SR. Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: no causal relation with diabetic autonomic neuropathy. Br Med J 1990; 301: 783-787.
38. 38 Hepburn DA, Patrick AW, Eadington DW, Ewing DJ, Frier BM. Unawareness of hypoglycaemia in insulin treated diabetic patients: prevalence and relationship to autonomic neuropathy. Diabetic Med 1990; 7: 711-717.
39. 39 Töyry JP, Niskanen LK, Mantysaari MJ, Lansimies EA, Uusitupa MI. Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM. Ten-year follow-up from the diagnosis. Diabetes 1996; 45: 308-315.
40. 40 Töyry JP, Niskanen LK, Mantysaari MJ, Lansimies EA, Haffner SM, Miettinen HJ et al. Do high proinsulin and C-peptide levels play a role in autonomic nervous dysfunction?: Power spectral analysis in patients with non-insulin-dependent diabetes and nondiabetic subjects. Circulation 1997; 96: 1185-1191.
41. 41 Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin dependent diabetes mellitus. N Engl J Med 1995; 333: 89-94.
42. 42 Sundkvist G, Lilja B, Nilsson H, Nilsson JA, Rosén I. Peripheral nerve dysfunction is reflected by loss of ankle reflexes but not by autonomic neuropathy in diabetic patients. Muscle Nerve 1997; 20: 740-743.
43. 43 Töyry JP, Partanen JVS, Niskanen LK, Länsimies EA, Uusitupa MIJ. Divergent development of autonomic and peripheral somatic neuropathies in NIDDM. Diabetologia 1997; 40: 953-958.
44. 44 NDDG National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039-1057.